The expert line-up for BioM's "AI4Biotech Session – Biotech AI Compass: Lead Your Organization Through the AI Transition" is complete: Dr. Anna Bauer-Mehren, a trained bioinformatician who heads the Integrated Clinical Analytics Chapter at Roche Information Solutions (Roche Diagnostics) and previously spent more than ten years in Roche Pharma Research and Early Development (pRED), will join the session as thought leader. She also serves on the Bavarian AI Council (co-lead since 2026) and brings a first-hand perspective on how a leading pharma and diagnostics organization translates AI from ambition into operational reality.
Date: 21 July 2026 | 9 am – 8 pm (+ follow-up check-in sessions)
Location: BioM, Room Munich, Am Klopferspitz 19a, Martinsried (Munich)
Language: English
Secure your spot now – Early bird rate available until July 12!
AI is rapidly redefining how organizations in biotech and life sciences innovate, operate, and compete. The one-day session helps decision-makers turn AI uncertainty into strategic action: participants gain a realistic understanding of AI in life sciences, assess their organization's AI readiness, use a practical framework to prioritize relevant initiatives, and develop an AI roadmap tailored to their organization.
Distinctive features:
Up to three 90-minute follow-up sessions after the workshop, supporting sustainable implementation in your own organization
Peer exchange with biotech and life science leaders
Fireside chat & impulse with thought leader Dr. Anna Bauer-Mehren (Roche Diagnostics, Bavarian AI Council)
Led by experts from Steadforce (www.steadforce.com), the session is designed for decision-makers across the biotech and life sciences ecosystem. No technical background required.
Seats are limited to ensure a highly interactive and personal exchange.
Secure your spot now – Early bird rate available until July 12!
For more information and registration, please see the event page.